SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AeroVironment, Inc. engages in the design, development, and production of multi-domain robotic systems and related services for government agencies and businesses. It operates through the following business segments: UnCrewed Systems, Loitering Munitions Systems, and MacCready Work. The UnCrewed Systems segment focuses primarily on small UAS products designed to operate reliably at lower altitudes in a wide range of environmental conditions. The Loitering Munitions Systems segment focuses primarily on tube-launched aircraft that deploy with the push of a button, fly at higher speeds than small UAS products, and perform either effects delivery or reconnaissance missions, and related support services including training, spare parts, product repair, and product replacement. The MacCready Works segment focuses on customer-funded research and development in the areas of HAPS, robotics, sensors, software analytics, data intelligence, and connectivity. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending following a double downgrade from Raymond James, driven by the U.S. Space Force's decision to recompete the $1.4B SCAR program, AeroVironment's largest contract. This news sparked a sharp sell-off, igniting community debate over whether the market is overreacting or legitimately repricing future revenue visibility.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil is trending as escalating Middle East tensions drive up oil prices, with the community actively discussing its substantial price action and anticipating a significant short squeeze due to high borrow rates and minimal shares available to short.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is trending as escalating Middle East tensions, including drone strikes on oil facilities and LNG production halts, ignite strong community debate about surging energy prices and the stock's potential for a significant speculative run, though some warn of manipulation and dilution.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Speculation is rampant around POET Technologies as NVIDIA's increasing focus on optical interconnects for AI data centers and Marvell's acquisition of Celestial AI validate the photonics sector, with the community anticipating significant partnership announcements and a revenue ramp, potentially coinciding with the upcoming OFC conference.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is a central topic of discussion amid rising geopolitical tensions and the US Army's "Drone Dominance Program," with the community actively speculating on unprecedented demand for its drone and robotic solutions. Recent institutional boosts and public endorsements from military figures are fueling excitement for potential significant government contracts.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

The recent regulatory setback for a key competitor's Cushing's drug is driving significant attention to Xeris Biopharma, further fueled by robust financial performance and the advancement of a major pipeline candidate into Phase 3. While the company demonstrates strong fundamentals and growth potential, community discussions reflect ongoing frustration with the stock's pronounced volatility despite these positive developments.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as strategic partnerships with NVIDIA and Amazon AWS solidify its role in building next-generation AI-ready 5G and 6G network infrastructure. The community is buzzing with optimism, eyeing a potential breakout and recognizing the company's transformation as a key enabler of the AI supercycle.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending amid a strong earnings report and a new LNG supply agreement, with the community highly focused on how escalating geopolitical tensions in the Middle East, including disruptions to Qatar's LNG production, amplify the immediate demand for its rapidly expanding export capacity.

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Aldeyra Therapeutics Inc

Aldeyra Therapeutics is seeing intense debate and volatility as its PDUFA date approaches for reproxalap, with community members clashing over the significance of recent financial disclosures, the CEO's conference remarks, a key executive's departure, and the FDA's silence on a critical labeling communication deadline, fueling both strong approval hopes and fears of a third Complete Response Letter.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics (NTLA) is seeing significant investor attention and a surge in price after the FDA lifted the clinical hold on its MAGNITUDE-2 Phase 3 trial. This development, coupled with high short interest, is fueling strong short squeeze sentiment and optimism among the community that the stock will return to prior levels, especially given discussions around the patient death being unrelated to the therapy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

West Pharmaceutical Services, Inc. $WST Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 3.3% during the 3rd quarter, according to its most recent 13F...

APG Asset Management N.V. Sells 244,966 Shares of West Pharmaceutical Services, Inc. $WST

APG Asset Management N.V. cut its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 14.8% during the third quarter, according to the company in its most recent 13F...

Findlay Park Partners LLP Has $210.42 Million Position in West Pharmaceutical Services, Inc. $WST

Findlay Park Partners LLP lessened its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 1.8% in the third quarter, according to the company in its most recent filing...

West to Participate in Upcoming Investor Conferences

West to Participate in Upcoming Investor Conferences West to Participate in Upcoming Investor Conferences PR Newswire EXTON, Pa., Feb. 27, 2026 EXTON, Pa., Feb. 27, 2026 /PRNewswire/ -- West...

Citigroup Inc. Has $21.71 Million Stake in West Pharmaceutical Services, Inc. $WST

Citigroup Inc. trimmed its stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 12.9% during the third quarter, according to its most recent disclosure with the Securities and...

Artisan Partners Limited Partnership Increases Stake in West Pharmaceutical Services, Inc. $WST

Artisan Partners Limited Partnership grew its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 22.2% in the third quarter, according to the company in its most recent...

TD Asset Management Inc Has $159.06 Million Position in West Pharmaceutical Services, Inc. $WST

TD Asset Management Inc raised its holdings in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 26.1% during the third quarter, according to the company in its most recent Form 13F...

Why West Pharmaceutical Services (WST) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

JPMorgan Chase & Co. Grows Holdings in West Pharmaceutical Services, Inc. $WST

JPMorgan Chase & Co. lifted its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 7.7% in the third quarter, according to the company in its most recent disclosure...

Generation Investment Management LLP Sells 189,763 Shares of West Pharmaceutical Services, Inc. $WST

Generation Investment Management LLP reduced its position in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 16.3% in the third quarter, according to its most recent disclosure with...

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

West Pharmaceutical Services, Inc.

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $MDB earnings today?

Current Price	$251.10
Prev Close	$254.34
Open	$250.71
Dividend Yield	0.31%
50-Day Moving Average	$256.80
Beta	0.70
Avg. Volume	1.03M
PE Ratio	37.44

52-Week High	$322.34
52-Week Low	$187.43
Market Capitalization	$18.62B
EPS (Annual)	$6.79
Price to Book	5.77
Revenue Per Employee	$284,694.44

WST
West Pharmaceutical Services, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest WST News

WSTWest Pharmaceutical Services, Inc.